戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  change in phosphocholine mass (a measure of phosphatidylcholine-specific phospholipase C).
2  factor 1, insulin-like growth factor 2, and phosphatidylcholine-specific phospholipase C.
3 Etn-BHQ, a NIR fluorescent probe specific to phosphatidylcholine-specific phospholipase C.
4 vation of B. anthracis hemolysins, including phosphatidylcholine-specific phospholipase C and sphingo
5 ently shown that IL-3R occupancy activates a phosphatidylcholine-specific phospholipase C, and the su
6                        D609, an inhibitor of phosphatidylcholine-specific phospholipase C, completely
7                  We investigated the role of phosphatidylcholine-specific phospholipase C in the indu
8 hibitors of sPLA2-I, by indomethacin, by the phosphatidylcholine-specific phospholipase C inhibitor D
9                                      D609, a phosphatidylcholine-specific phospholipase C inhibitor,
10      The results of this study indicate that phosphatidylcholine-specific phospholipase C is required
11 etreatment with D609, an agent that inhibits phosphatidylcholine-specific phospholipase C, neither in
12 B. cereus results largely from the action of phosphatidylcholine-specific phospholipase C (PC-PLC) an
13                                              Phosphatidylcholine-specific phospholipase C (PC-PLC) is
14 phocholine (ChoP), a reaction product of the phosphatidylcholine-specific phospholipase C (PC-PLC) of
15 L. pneumophila proteins with homology to the phosphatidylcholine-specific phospholipase C (PC-PLC) of
16 ositol-specific phospholipase C (PI-PLC) and phosphatidylcholine-specific phospholipase C (PC-PLC) to
17 reatment with D609, a selective inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC), i
18 er the relationship of SMS to the "putative" phosphatidylcholine-specific phospholipase C (PC-PLC).
19                          D609 which inhibits phosphatidylcholine-specific phospholipase-C (PLC), pote
20 ggest that phosphatidylinositol 3-kinase and phosphatidylcholine-specific phospholipase C represent c
21 nd activation of Gi3-linked receptors and of phosphatidylcholine-specific phospholipase C, resulting
22                       cPLA2alpha inactivates phosphatidylcholine-specific phospholipase C to inhibit
23           Of significance, an inhibitor of a phosphatidylcholine-specific phospholipase C, tricyclode